Product Information
MIEBO 100% EYE DROP is a brand product labeled by Bausch & Lomb Incorporated, priced at $263.5666 per ML under NDC 24208037705. Its NADAC has been published 142 times since Jan 17, 2024.
FDA first approved this application on May 18, 2023.
Strength
1 mg/mg
Manufacturer
Bausch & Lomb IncorporatedNDC
24208037705
Classification
Brand
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
PERFLUOROHEXYLOCTANEApproval Type
New Drug (NDA)
FDA Application
NDA216675FDA Approved
5/18/2023
On Market Since
5/18/2023
Pharmacological Classes
Price Statistics
The NADAC for MIEBO 100% EYE DROP has been published 142 times since Jan 17, 2024, and over the history we have for it it has risen 6.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $263.5666 per ML |
|---|---|
| All-time high | $263.7951 (May 13, 2026) |
| All-time low | $246.5697 (Dec 18, 2024) |
| 52-week high | $263.7951 |
| 52-week low | $256.0527 |
| Median price | $256.0952 |
| Average price | $254.8402 |
| Largest weekly change | +4.0% (Jan 8, 2025) |
| Weeks tracked | 142 |
| Tracking since | Jan 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Perfluorohexyloctane market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch & Lomb Incorporated manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Perfluorohexyloctane market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MIEBO 100% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for MIEBO 100% EYE DROP, manufactured by Bausch & Lomb Incorporated, is $263.5666 per ML (NDC 24208037705), effective Sep 30, 2026.
How has the price of MIEBO 100% EYE DROP changed over time?
Over the history we have for it, the NADAC for MIEBO 100% EYE DROP has risen 6.8%. It has been tracked across 142 weekly CMS publications since Jan 17, 2024.
What are the highest and lowest recorded NADAC prices for MIEBO 100% EYE DROP?
Since Jan 17, 2024, the NADAC for MIEBO 100% EYE DROP has ranged from a low of $246.5697 (Dec 18, 2024) to a high of $263.7951 (May 13, 2026), with a median of $256.0952 per ML.
Are there cheaper alternatives to MIEBO 100% EYE DROP?
No other NADAC-published product currently shares the active ingredient and strength of MIEBO 100% EYE DROP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MIEBO 100% EYE DROP?
MIEBO 100% EYE DROP (NDC 24208037705) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a brand product.